Literature DB >> 3042353

Responders and non-responders to antihypertensive treatment.

C J Bulpitt1.   

Abstract

Responders to antihypertensive treatment have been defined as any patient with a fall in mean arterial pressure, however small; any patient with a fall in mean arterial pressure of 5%, 10% or greater; and any patient achieving a goal blood pressure, usually a diastolic pressure less than 90 mm Hg. Non-responders are normally defined as those who do not fit into the category of a responder. Blood pressure, however, varies considerably during follow-up, and diastolic pressure has a within-subject standard deviation of 8 mm Hg. Blood pressure varies according to environmental factors such as temperature, diet and stress, and tends to drift downwards during follow-up as the patient becomes accustomed to having blood pressure taken, to the place of measurement and to the observer. In a statistical sense, responders may be defined as the 2.5% with a fall in DBP greater than 16 mm Hg, yet in clinical studies of a low sodium diet reports have indicated that 50% have experienced an increase in pressure and 50% a fall (responders). Although the characteristics of those with a fall in pressure are of interest and should be compared with those who do not respond, a 50:50 division is unlikely to help. Methods of identifying true responders and non-responders are discussed in this brief review, along with the errors that may arise from a misclassification and problems of conducting further trials of treatment on the non-responders.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042353     DOI: 10.2165/00003495-198800356-00019

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  15 in total

1.  The acute antihypertensive effect of ketanserin increases with age.

Authors:  J De Crée; M Hoing; M De Ryck; J Symoens
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

2.  Misleading paper about misleading statistics.

Authors: 
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

3.  Relation between initial blood pressure and its fall with treatment.

Authors:  J S Gill; A V Zezulka; D G Beevers; P Davies
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

4.  Ketanserin--a new antihypertensive agent.

Authors:  A Breckenridge
Journal:  J Hypertens Suppl       Date:  1986-04

5.  Factors influencing blood pressure in salt-sensitive patients with hypertension.

Authors:  T Fujita; W L Henry; F C Bartter; C R Lake; C S Delea
Journal:  Am J Med       Date:  1980-09       Impact factor: 4.965

6.  Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo.

Authors:  W J Mroczek; S Fotiu; M E Davidov; F A Finnerty
Journal:  Curr Ther Res Clin Exp       Date:  1974-08

7.  The variability of measurements of casual blood pressure. I. A laboratory study.

Authors:  P Armitage; G A Rose
Journal:  Clin Sci       Date:  1966-04       Impact factor: 6.124

8.  Evidence for altered vascular reactivity in sodium-sensitive young subjects with borderline hypertension.

Authors:  J M Sullivan; T E Ratts; S W Reed; A Banna; J C Riddle; C Jordan
Journal:  Am J Med Sci       Date:  1984-09       Impact factor: 2.378

9.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

10.  The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension.

Authors:  T Kawasaki; C S Delea; F C Bartter; H Smith
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

View more
  1 in total

1.  The effect of aged garlic extract on blood pressure and other cardiovascular risk factors in uncontrolled hypertensives: the AGE at Heart trial.

Authors:  Karin Ried; Nikolaj Travica; Avni Sali
Journal:  Integr Blood Press Control       Date:  2016-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.